Certain Antivenom Compositions and Products Containing the Same Commission Determination Not To Review an Initial Determination Terminating the Investigation Based on a Settlement Agreement; Termination of the Investigation, 73336 [2014-28901]

Download as PDF 73336 Federal Register / Vol. 79, No. 237 / Wednesday, December 10, 2014 / Notices investigation is, hereby, terminated with respect to the Wild Patents. The authority for the Commission’s determination is contained in section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and in Part 210 of the Commission’s Rules of Practice and Procedure (19 CFR part 210). Dated: December 4, 2014. By order of the Commission. Lisa R. Barton, Secretary to the Commission. [FR Doc. 2014–28871 Filed 12–9–14; 8:45 am] BILLING CODE 7020–02–P INTERNATIONAL TRADE COMMISSION [Investigation No. 337–TA–903] Certain Antivenom Compositions and Products Containing the Same Commission Determination Not To Review an Initial Determination Terminating the Investigation Based on a Settlement Agreement; Termination of the Investigation U.S. International Trade Commission. ACTION: Notice. AGENCY: Notice is hereby given that the U.S. International Trade Commission has determined not to review an initial determination (‘‘ID’’) (Order No. 62) issued by the presiding administrative law judge (‘‘ALJ’’) on November 13, 2014, terminating the investigation based on a settlement agreement. SUMMARY: mstockstill on DSK4VPTVN1PROD with NOTICES FOR FURTHER INFORMATION CONTACT: Robert Needham, Office of the General Counsel, U.S. International Trade Commission, 500 E Street SW., Washington, DC 20436, telephone (202) 708–5468. Copies of non-confidential documents filed in connection with this investigation are or will be available for inspection during official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. International Trade Commission, 500 E Street SW., Washington, DC 20436, telephone (202) 205–2000. General information concerning the Commission may also be obtained by accessing its Internet server (http://www.usitc.gov). The public record for this investigation may be viewed on the Commission’s electronic docket (EDIS) at http:// edis.usitc.gov. Hearing-impaired persons are advised that information on this matter can be obtained by contacting the Commission’s TDD terminal on (202) 205–1810. VerDate Sep<11>2014 17:48 Dec 09, 2014 Jkt 235001 The Commission instituted this investigation on December 11, 2013, based on a complaint filed by BTG International Inc. (‘‘BTG’’) of West Conshohocken, Pennsylvania. 78 FR 75372–73. The complaint alleges violations of section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, in the importation into the United States, the sale for importation, and the sale within the United States after importation of certain antivenom compositions and products containing the same through the infringement of certain claims of U.S. Patent No. 8,048,414. Id. at 75373. The Commission’s notice of investigation named as respondents Veteria Laboratories of Mexico and BioVeteria Life Sciences, LLC of Prescott, Arizona (together, ‘‘Veteria’’); Instituto Bioclon S.A. de C.V. of Mexico, Laboratorios Silanes S.A. de C.V. of Mexico, and Rare Disease Therapeutics, Inc., of Franklin, Tennessee (collectively, ‘‘Respondents’’); and the Silanes Group of Mexico. Id. The Commission previously terminated the investigation with respect to Veteria based on a partial withdrawal of the complaint. Order No. 14 (Mar. 11, 2014), not reviewed Apr. 1, 2014. The Office of Unfair Import Investigations was also named as a party to the investigation. 78 FR 75373. On October 10, 2014, BTG and Respondents filed a joint motion to terminate the investigation in its entirety based on a settlement agreement. The motion attached confidential and public versions of the settlement agreement and stated that there were no other agreements, written or oral, express or implied, between BTG and Respondents. The motion also stated that terminating the investigation would not adversely affect the public interest. On October 23, 2014, the Commission Investigative Attorney (‘‘IA’’) filed a response in support of the parties’ motion. The IA stated that the termination of the investigation was in the public interest. On October 30, 2014, the parties filed a modified public version of the settlement agreement with fewer redactions. On November 13, 2014, the ALJ issued the subject ID, granting the parties’ motion and terminating the investigation in its entirety. The ALJ found that the motion complied with the Commission rules and does not impose any undue burden on the public interest. The Commission has determined not to review the subject ID. The authority for the Commission’s determination is contained in section SUPPLEMENTARY INFORMATION: PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and in Part 210 of the Commission’s Rules of Practice and Procedure (19 CFR part 210). Issued: December 5, 2014. By order of the Commission. Lisa R. Barton, Secretary to the Commission. [FR Doc. 2014–28901 Filed 12–9–14; 8:45 am] BILLING CODE 7020–02–P INTERNATIONAL TRADE COMMISSION [Investigation No. 337–TA–938] Certain Coaxial Cable Connectors and Components Thereof and Products Containing Same Institution of Investigation U.S. International Trade Commission. ACTION: Notice. AGENCY: Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on November 5, 2014, under section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, on behalf of PPC Broadband, Inc. of East Syracuse, New York. Supplements to the complaint were filed on November 17 and 20, 2014. The complaint, as supplemented, alleges violations of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain coaxial cable connectors and components thereof and products containing same by reason of infringement of certain claims of U.S. Patent No. 8,801,448 (‘‘the ‘448 patent’’). The complaint further alleges that an industry in the United States exists as required by subsection (a)(2) of section 337. The complainant requests that the Commission institute an investigation and, after the investigation, issue a limited exclusion order and cease and desist order. ADDRESSES: The complaint, except for any confidential information contained therein, is available for inspection during official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. International Trade Commission, 500 E Street SW., Room 112, Washington, DC 20436, telephone (202) 205–2000. Hearing impaired individuals are advised that information on this matter can be obtained by contacting the Commission’s TDD terminal on (202) 205–1810. Persons SUMMARY: E:\FR\FM\10DEN1.SGM 10DEN1

Agencies

[Federal Register Volume 79, Number 237 (Wednesday, December 10, 2014)]
[Notices]
[Page 73336]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-28901]


-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 337-TA-903]


Certain Antivenom Compositions and Products Containing the Same 
Commission Determination Not To Review an Initial Determination 
Terminating the Investigation Based on a Settlement Agreement; 
Termination of the Investigation

AGENCY: U.S. International Trade Commission.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the U.S. International Trade 
Commission has determined not to review an initial determination 
(``ID'') (Order No. 62) issued by the presiding administrative law 
judge (``ALJ'') on November 13, 2014, terminating the investigation 
based on a settlement agreement.

FOR FURTHER INFORMATION CONTACT: Robert Needham, Office of the General 
Counsel, U.S. International Trade Commission, 500 E Street SW., 
Washington, DC 20436, telephone (202) 708-5468. Copies of non-
confidential documents filed in connection with this investigation are 
or will be available for inspection during official business hours 
(8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. 
International Trade Commission, 500 E Street SW., Washington, DC 20436, 
telephone (202) 205-2000. General information concerning the Commission 
may also be obtained by accessing its Internet server (http://www.usitc.gov). The public record for this investigation may be viewed 
on the Commission's electronic docket (EDIS) at http://edis.usitc.gov. 
Hearing-impaired persons are advised that information on this matter 
can be obtained by contacting the Commission's TDD terminal on (202) 
205-1810.

SUPPLEMENTARY INFORMATION: The Commission instituted this investigation 
on December 11, 2013, based on a complaint filed by BTG International 
Inc. (``BTG'') of West Conshohocken, Pennsylvania. 78 FR 75372-73. The 
complaint alleges violations of section 337 of the Tariff Act of 1930, 
as amended, 19 U.S.C. 1337, in the importation into the United States, 
the sale for importation, and the sale within the United States after 
importation of certain antivenom compositions and products containing 
the same through the infringement of certain claims of U.S. Patent No. 
8,048,414. Id. at 75373. The Commission's notice of investigation named 
as respondents Veteria Laboratories of Mexico and BioVeteria Life 
Sciences, LLC of Prescott, Arizona (together, ``Veteria''); Instituto 
Bioclon S.A. de C.V. of Mexico, Laboratorios Silanes S.A. de C.V. of 
Mexico, and Rare Disease Therapeutics, Inc., of Franklin, Tennessee 
(collectively, ``Respondents''); and the Silanes Group of Mexico. Id. 
The Commission previously terminated the investigation with respect to 
Veteria based on a partial withdrawal of the complaint. Order No. 14 
(Mar. 11, 2014), not reviewed Apr. 1, 2014. The Office of Unfair Import 
Investigations was also named as a party to the investigation. 78 FR 
75373.
    On October 10, 2014, BTG and Respondents filed a joint motion to 
terminate the investigation in its entirety based on a settlement 
agreement. The motion attached confidential and public versions of the 
settlement agreement and stated that there were no other agreements, 
written or oral, express or implied, between BTG and Respondents. The 
motion also stated that terminating the investigation would not 
adversely affect the public interest.
    On October 23, 2014, the Commission Investigative Attorney (``IA'') 
filed a response in support of the parties' motion. The IA stated that 
the termination of the investigation was in the public interest. On 
October 30, 2014, the parties filed a modified public version of the 
settlement agreement with fewer redactions.
    On November 13, 2014, the ALJ issued the subject ID, granting the 
parties' motion and terminating the investigation in its entirety. The 
ALJ found that the motion complied with the Commission rules and does 
not impose any undue burden on the public interest.
    The Commission has determined not to review the subject ID.
    The authority for the Commission's determination is contained in 
section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and 
in Part 210 of the Commission's Rules of Practice and Procedure (19 CFR 
part 210).


    Issued: December 5, 2014.

    By order of the Commission.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2014-28901 Filed 12-9-14; 8:45 am]
BILLING CODE 7020-02-P